DrugPatentWatch Database Preview
Siga Technologies Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for SIGA TECHNOLOGIES, and when can generic versions of SIGA TECHNOLOGIES drugs launch?
SIGA TECHNOLOGIES has one approved drug.
There are six US patents protecting SIGA TECHNOLOGIES drugs.
There are sixty-seven patent family members on SIGA TECHNOLOGIES drugs in twenty-one countries.
Summary for Siga Technologies
| International Patents: | 67 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Siga Technologies
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 9,339,466 | Start Trial | Y | Y | Start Trial | ||
| Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 8,124,643 | Start Trial | Y | Y | Start Trial | ||
| Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 7,737,168 | Start Trial | Start Trial | ||||
| Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | 8,530,509 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Siga Technologies Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2866037 | Start Trial |
| South Africa | 201207141 | Start Trial |
| Canada | 3030671 | Start Trial |
| Peru | 20170944 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
